Warner Chilcott (formerly Galen) was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis (now Allergan).
|Defunct||October 1, 2013|
|Fate||Acquired by Actavis (now Allergan)|
|Headquarters||Rockaway, New Jersey|
Predecessor companies edit
Warner Chilcott edit
In 1996, it was sold to Nale Laboratories P.L.C.
Merger of Galen and Warner Chilcott edit
In 2004, the company changed its name from Galen to Warner Chilcott.
In August 2004, the company prevailed in a patent case by Teva Pharmaceutical Industries related to Sarafem (Fluoxetine). On May 19, 2006, the company received approval from the Food and Drug Administration for Sarafem.
- Carroll, Steven (October 20, 2009). "Warner Chilcott: company history". The Irish Times.
- "WARNER-LAMBERT TO SELL GENERIC UNIT TO NALE". The New York Times. Bloomberg Business News. March 2, 1996.
- "Warner Chilcott's I.P.O. Prices Below Expected Range". The New York Times. September 21, 2006.(subscription required)
- "Galen to change name to Warner Chilcott". The Irish Times. May 12, 2004.
- Meland, Marius (August 6, 2004). "Warner Chilcott Prevails Vs. Teva In Sarafem Patent Suit". Law360.
- "Sarafem (fluoxetine hydrochloride) Tablets". Food and Drug Administration. May 19, 2006.
- "Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business" (Press release). Evaluate Group. October 30, 2009.
- "Actavis Completes Warner Chilcott Acquisition" (Press release). PR Newswire. October 1, 2013.